Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.0 deployed.
    Difference
    0.0%
    Check dated 2026-03-20T01:22:14.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3; no user-visible changes to the study page.
    Difference
    0.0%
    Check dated 2026-03-12T21:00:05.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    A minor page revision was applied, moving from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:41:51.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Only a page revision update from v3.4.0 to v3.4.1 is visible; no core content or study data changes were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:06:54.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    UI and metadata elements were updated, including a visible 'Show glossary' label and capitalization adjustments to the QC-related update text. A site revision banner now shows v3.4.0, replacing the previous v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T21:32:51.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no substantive changes to study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:53:40.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.